Literature DB >> 27475111

Serum cytokine profile contributes to discriminating M. pneumoniae pneumonia in children.

Xue-Feng Xu1, Xue-Jing Li1, Jin-Ling Liu1, Lei Wu1, Zhi-Min Chen2.   

Abstract

BACKGROUND: To evaluate the role of serum cytokines in discriminating M. pneumoniae infection in children with community-acquired pneumonia (CAP).
METHODS: A prospective observational study was conducted. 385 hospitalized patients with CAP had only M. pneumoniae (MP group) infection; 321 hospitalized patients with CAP had no M. pneumoniae and other specific pathogen (control group) infections. Serum interleukin-2 (IL-2), IL-4, IL-6, IL-10, tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) were detected by flow cytometry.
RESULTS: In children younger than 5years, serum IL-6, TNF-α, and IFN-γ levels from MP group were significantly higher than those from control group. However in children 5-15years, serum IL-6, IL-10, and IFN-γ levels from MP group were significantly higher than those from control group. In the final multivariate logistic regression model for serum cytokine, moderately elevated IL-6, IL-10, and IFN-γ shows a higher prediction of development of M. pneumoniae pneumonia among CAP patients.
CONCLUSIONS: A specific cytokine pattern showed a higher prediction of M. pneumoniae pneumonia among CAP patients, further suggesting that serum cytokine pattern might be useful in differentiating infectious causative agents in children.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Community-acquired pneumonia; Cytokine; M. pneumoniae

Mesh:

Substances:

Year:  2016        PMID: 27475111     DOI: 10.1016/j.cyto.2016.07.018

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

1.  Pinocembrin Relieves Mycoplasma pneumoniae Infection‑Induced Pneumonia in Mice Through the Inhibition of Oxidative Stress and Inflammatory Response.

Authors:  JinMing Qian; Mei Xue
Journal:  Appl Biochem Biotechnol       Date:  2022-08-02       Impact factor: 3.094

2.  TIPE2 negatively regulates mycoplasma pneumonia-triggered immune response via MAPK signaling pathway.

Authors:  Yuanyuan Zhang; Shufen Mei; Yunlian Zhou; Dehua Yang; Ting Pan; Zhimin Chen; Qingqing Wang
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

3.  Serum Cytokines and FeNO in School-Aged Children with Mycoplasma pneumoniae Pneumonia.

Authors:  Hai-Li Jin; Lu Zhan; Shu-Fen Mei; Zheng-Yang Shao
Journal:  Med Sci Monit       Date:  2020-06-21

4.  Nomogram for Prediction of Bronchial Mucus Plugs in Children with Mycoplasma pneumoniae Pneumonia.

Authors:  Xuefeng Xu; Huiwen Li; Yuanjian Sheng; Lei Wu; Danli Wang; Lingyue Liu; Yu Tong; Zhimin Chen
Journal:  Sci Rep       Date:  2020-03-12       Impact factor: 4.379

5.  Cytokine Expression of Lung Bacterial Infection in Newly Diagnosed Adult Hematological Malignancies.

Authors:  Zengzheng Li; Zefeng Yang; Peng Hu; Xin Guan; Lihua Zhang; Jinping Zhang; Tonghua Yang; Chaoran Zhang; Renbin Zhao
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

6.  Fucoxanthin, a Marine Carotenoid, Suppresses Mycoplasma pneumoniae-Triggered Inflammatory Cytokine Production and Promotes Bacterial Clearance in a Murine Model.

Authors:  Hongbo Wu; Shu Li; Linlin Wang; Jun Liang; Lei Yan; Jianjiang Dong
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-21       Impact factor: 2.650

7.  Low birth weight contributed to increased serum IL-6 levels in infantile respiratory syncytial virus infection.

Authors:  Yuan-Jian Sheng; Shan-Shan Xu; Xue-Jing Li; Jin-Ling Liu; Xi-Ling Wu; Xue-Feng Xu
Journal:  BMC Pediatr       Date:  2017-12-16       Impact factor: 2.125

8.  Ameliorative Effects of Infantile Feire Kechuan Oral Solution on Mycoplasma Pneumoniae Pneumonia in Infant Mouse and Rat Models.

Authors:  Shanshan Guo; Lei Bao; Tiange Qu; Xin Mao; Yingjie Gao; Yingli Xu; Xiaolan Cui
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-17       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.